tiprankstipranks
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
AARD
Aardvark Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see AARD full AI Analyst Report?

Aardvark Therapeutics, Inc. (AARD) Income Statement

153 Followers

Aardvark Therapeutics, Inc. Income Statement

Last quarter (Q1 2026), Aardvark Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Aardvark Therapeutics, Inc.'s net income was $-21.59M. See Aardvark Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -36.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 62.73M$ 22.79M$ 7.42M$ 11.36M
Depreciation and Amortization
$ 0.00$ 16.00K$ 0.00$ 110.00K
EBITDA
$ -62.73M$ -22.65M$ -6.65M$ -9.76M
Operating Income
$ -62.73M$ -22.79M$ -7.42M$ -11.36M
Other Income/Expenses
$ 5.13M$ 2.20M$ 207.00K$ -2.20M
Pretax Income
$ -57.59M$ -20.59M$ -7.21M$ -13.56M
Net Income
$ -57.59M$ -20.59M$ -7.21M$ -13.56M
Per Share Metrics
Basic EPS
$ -2.64$ -0.95$ -0.34$ -0.63
Diluted EPS
$ -2.64$ -0.95$ -0.34$ -0.63
Weighted Average Shares Outstanding
 21.82M 21.70M 21.38M 21.38M
Weighted Average Shares Outstanding (Diluted)
 21.82M 21.70M 21.38M 21.38M
Currency in USD

Aardvark Therapeutics, Inc. Earnings and Revenue History